EP0964698A4 - Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin - Google Patents

Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin

Info

Publication number
EP0964698A4
EP0964698A4 EP97950697A EP97950697A EP0964698A4 EP 0964698 A4 EP0964698 A4 EP 0964698A4 EP 97950697 A EP97950697 A EP 97950697A EP 97950697 A EP97950697 A EP 97950697A EP 0964698 A4 EP0964698 A4 EP 0964698A4
Authority
EP
European Patent Office
Prior art keywords
candida
mimic
vaccine
peptides
carbohydrate epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97950697A
Other languages
German (de)
English (en)
Other versions
EP0964698A1 (fr
Inventor
Jim E Cutler
Yongmoon Han
Pati Glee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Montana State University
Original Assignee
Montana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montana State University filed Critical Montana State University
Publication of EP0964698A1 publication Critical patent/EP0964698A1/fr
Publication of EP0964698A4 publication Critical patent/EP0964698A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP97950697A 1996-11-25 1997-11-25 Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin Withdrawn EP0964698A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75601496A 1996-11-25 1996-11-25
US756014 1996-11-25
US4503097P 1997-04-28 1997-04-28
US45030P 1997-04-28
PCT/US1997/021661 WO1998023287A1 (fr) 1996-11-25 1997-11-25 Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin

Publications (2)

Publication Number Publication Date
EP0964698A1 EP0964698A1 (fr) 1999-12-22
EP0964698A4 true EP0964698A4 (fr) 2004-10-27

Family

ID=26722293

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950697A Withdrawn EP0964698A4 (fr) 1996-11-25 1997-11-25 Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin

Country Status (4)

Country Link
EP (1) EP0964698A4 (fr)
AU (1) AU5363398A (fr)
CA (1) CA2272632A1 (fr)
WO (1) WO1998023287A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165614A4 (fr) * 1999-03-01 2002-06-26 Univ Montana Res Dev Inst Anticorps diriges contre le phosphomannane et protecteurs contre les candidoses
GB201307501D0 (en) * 2013-04-25 2013-06-12 Univ Aberdeen Anti-fungal antibody molecules and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2657495A (en) * 1994-05-23 1995-12-18 Research And Development Institute, Inc. Candida albicans adhesin as a vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAN Y ET AL: "Specificity of an antibody that protects mice against disseminated candidiasis", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 96, no. 0, 1996, & 96TH GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY; NEW ORLEANS, LOUISIANA, USA; MAY 19-23, 1996, pages 88, XP002294577, ISSN: 1060-2011 *

Also Published As

Publication number Publication date
EP0964698A1 (fr) 1999-12-22
AU5363398A (en) 1998-06-22
CA2272632A1 (fr) 1998-06-04
WO1998023287A1 (fr) 1998-06-04

Similar Documents

Publication Publication Date Title
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
EP0728014A4 (fr) Vaccins exprimes dans des plantes
AP9901432A0 (en) Hiv envelope polypeptides and vaccine
IL126736A0 (en) Verifying hardware in its software context and vice-versa
AU7789194A (en) Improvements in and relating to vaccines
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
NZ230773A (en) Nematode antigenic peptides and vaccines
GB9520497D0 (en) Improvements in turbines and compressors
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL129530A (en) Acellular pertussis vaccine with diphtheria and tetanus-toxoids
GB9516293D0 (en) Novel peptides and their use as vaccines
GB9518209D0 (en) Improvements in quilts and the like
ZA9410318B (en) Phenylmethyl hexanamides and the use thereof
ZA96240B (en) Novel peptides their preparation and use
EP0964698A4 (fr) Peptides imitant des epitopes d'hydrates de carbone de candida et leur utilisation dans un vaccin
IL116658A0 (en) Peptides their preparation and use
ZA973275B (en) Fluoroionophores and their use in optical sensors.
IL122686A0 (en) Benzylhydroxylamines their preparation and use
EP0875628A4 (fr) Revetement, ensemble d'unites de maintien pour pierres naturelles et unites de maintien pour pierres naturelles
PL330068A1 (en) Proteins constituting a transparent sheath used in contraception
GB9625041D0 (en) Improvements in and relating surfaces
GB9805065D0 (en) Improvements in chairs
GB9512896D0 (en) Peptides for use in vaccines
GB9015885D0 (en) Improvements in seating and seating support structures
IL116541A (en) Helicobacter proteins and vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990623

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MONTANA STATE UNIVERSITY

A4 Supplementary search report drawn up and despatched

Effective date: 20040914

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061003

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1024626

Country of ref document: HK